We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Impac Acquires Intellidata

By HospiMedica staff writers
Posted on 04 Jun 2002
In a move that will extend its oncology management system, Impac Medical Systems, Inc. (Mountain View, CA, USA) has acquired Intellidata, Inc. (Woodbridge, VA, USA), a leading US clinical laboratory information system (LIS) supplier. Terms were not disclosed.

Intellidata markets the IntelliLab laboratory information system. Features include comprehensive barcode labeling, expert medical necessity checking, and Phone Home Diagnostics. Impac is a provider of integrated clinical and administrative management systems for cancer specialists. The acquisition will enable seamless reporting of laboratory results in Impac's electronic medical record, and an LIS solution that addresses both the clinical and business needs of cancer specialists. Intellidata will give Impac customers an integrated LIS solution and immediate access to critical lab values at the point of care.

"Impac chose Intellidata as its LIS solution because the system provides sophisticated clinical analysis, connects to virtually any lab device, and supports the business requirements of the cancer center,” said Joe Jachinowski, president and CEO of Impac.




Related Links:
Impac
Intellidata

New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
PSA Test
Human Semen Rapid Test
New
Malaria Rapid Test
OnSite Malaria Pf/Pan Ag Rapid Test

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests